Contribution: Industrial Research Assistance Program – Contributions to Firms
RPS Biologiques Inc.
$49,645.00
Pilot Study to Assess Efficacy and Safety of a Novel Bath/Wash Treatment Against Sea Lice
FY 2018-19 · 2018-12-03
Summary
Infections by the parasitic copepod sea lice continue to be a challenge to most Atlantic salmon farming regions of the world, including Atlantic Canada. These host-specific parasites are very pathogenic to salmonid species (e.g. Atlantic salmon) especially populations in cage culture where the stocking density is unnaturally high. Large numbers of sea lice can quickly cause severe skin and tissue damage resulting in fish stress and mortality.
RPS Biologiques has developed a novel compound that will undergo pilot-testing prior to further pre-commercial development, to determine and compare the efficacy with other commercially available bath treatments.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Charlottetown|Charlottetown, Prince Edward Island, Canada
Recipient Type
For-profit organization
Business Number
808567390
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-12-03 | 2018-19 | $49,645.00 |
| 1 | 2018-12-03 | 2018-19 | $49,645.00 |
| 2 | 2018-12-03 | 2018-19 | $49,645.00 |
| 3 | 2018-12-03 | 2018-19 | $49,645.00 |
| 4 | 2018-12-03 | 2018-19 | $49,645.00 |
| 5 | 2018-12-03 | 2018-19 | $49,645.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 59 jours.
Agreement End Date
2021-03-31
Agreement Number
916911
Agreement Start Date
2018-12-03
Agreement Title
Pilot Study to Assess Efficacy and Safety of a Novel Bath/Wash Treatment Against Sea Lice
Agreement Title (French)
Étude pilote visant à évaluer l'efficacité et la sécurité d'un nouveau traitement pour le bain / lavage contre le pou de poisson
Agreement Type
Contribution
Agreement Value
$49,645.00
Amendment Date
2021-01-19
Amendment Number
5
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Infections by the parasitic copepod sea lice continue to be a challenge to most Atlantic salmon farming regions of the world, including Atlantic Canada. These host-specific parasites are very pathogenic to salmonid species (e.g. Atlantic salmon) especially populations in cage culture where the stocking density is unnaturally high. Large numbers of sea lice can quickly cause severe skin and tissue damage resulting in fish stress and mortality.
RPS Biologiques has developed a novel compound that will undergo pilot-testing prior to further pre-commercial development, to determine and compare the efficacy with other commercially available bath treatments.
Description (French)
Les infections par le pou de poisson copépode parasite continuent de poser des problèmes à la plupart des régions d'élevage du saumon de l'Atlantique, y compris le Canada atlantique. Ces parasites spécifiques à l'hôte sont très pathogènes pour les espèces de salmonidés (par exemple, le saumon atlantique), en particulier pour les populations en culture en cage où la densité d'empoissonnement est anormalement élevée. Un grand nombre de poux de poisson peut rapidement causer de graves dommages à la peau et aux tissus, entraînant un stress et une mortalité chez les poissons. RPS Biologiques a mis au point un nouveau composé qui fera l’objet de tests pilotes avant de poursuivre son développement pré-commercial afin de déterminer et de comparer son efficacité avec d’autres traitements de bain disponibles dans le commerce.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Charlottetown
Federal Riding (French)
Charlottetown
Federal Riding Number
11002
NAICS Code
32541
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
808567390
Recipient City
Charlottetown|Charlottetown
Recipient Country
CA
Recipient Legal Name
RPS Biologiques Inc.
Recipient Postal Code
C1A 3H4
Recipient Province or Territory
PE
Recipient Type
F
Reference Number
172-2018-2019-Q3-916911
